CLINDAMYCIN PHOSPHATE | A210778 | GLENMARK PHARMACEUTICALS LTD
| Case | Court | Filed | Status | Judge |
|---|---|---|---|---|
Delcor Asset Corporation et al v. Glenmark Pharmaceuticals Limited et al 2 patentsANDA 210778clindamycin phosphate | D. Del. | 2017-11-15 | Terminated 2019-03-05 | — |
Source: PACER. NOS 835 (Patent - Abbreviated New Drug Application).
Highest NADAC/Unit
$2.43
per gm
Lowest NADAC/Unit
$2.16
per gm
Brand NDCs
0
Generic NDCs
2
| NDC Description | NADAC/Unit | Unit | Type | Generic NADAC | Effective |
|---|---|---|---|---|---|
| 68462060527CLINDAMYCIN PHOSPHATE 1% FOAM | $2.43 | GM | Generic | — | 2026-06-17 |
| 68462060594CLINDAMYCIN PHOSPHATE 1% FOAM | $2.16 | GM | Generic | — | 2026-06-17 |
Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.
No patent or exclusivity listings for this strength.